Search - tctmd.com

Displaying 1 - 20 of 98

Sort: Relevancy | Date

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

Presentation TCT 2024

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

Presenter: Francesco Giannini

October 30, 2024

Presentation TCT 2024

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Presenter: James Min

October 30, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 104: Coronary Hematoma Was a Major Emergent Ischemic Cause After Successful PCI

Presenter: TAKUNORI TSUKUI

October 29, 2024

Presentation TCT 2024

TCT 298: Coronary Artery Bypass Grafting Versus Coronary Artery Bypass Grafting Plus Mitral Valve Surgery in Patients With Moderate Ischemic Mitral Regurgitation

Presenter: Abdul Wali Khan

October 29, 2024

Presentation TCT 2024

TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy

Presenter: Stephen Ellis

October 29, 2024

Presentation TCT 2024

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

Presenter: Stephen Ellis

October 29, 2024

Presentation TCT 2024

TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades

Presenter: Ahmed Abdulelah

October 29, 2024

Presentation TCT 2024

Case Presentation: Cardiogenic Shock in a Patient With Non-ischemic Cardiomyopathy

Presenter: Ann Gage

October 29, 2024

Presentation TCT 2024

TCT 792: Prognosis in Patients With Cardiogenic Shock According to Sex, With or Without Ischemic Cardiomyopathy

Presenter: CHANG HOON KIM

October 29, 2024

Presentation TCT 2024

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

Presenter: Mauro Gitto

October 27, 2024

Presentation TCT 2024

TCT 1351: Cangrelor in a Challenging Scenario of Concomitant Ischemic Stroke, Pulmonary Embolism and STEMI

Presenter: Federico Oliveri

October 27, 2024

Presentation TCT 2024

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

Presenter: Jeehoon Kang

October 27, 2024

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

Presentation TCT 2023

TCT 104: Prognostic Impact of Ischemic Territory and Revascularization Strategy in Acute Myocardial Infarction Complicating Cardiogenic Shock Patients with Multi-vessel Disease

Presenter: Sangyoon Lee

October 26, 2023

Presentation TCT 2023

TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions

Presenter: Eva Woelders

October 25, 2023

Presentation TCT 2023

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

Presenter: Cole Clifford

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2022

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Presenter: Jonathan Hill

September 18, 2022

Advertisement

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

TCT 104: Coronary Hematoma Was a Major Emergent Ischemic Cause After Successful PCI

TCT 298: Coronary Artery Bypass Grafting Versus Coronary Artery Bypass Grafting Plus Mitral Valve Surgery in Patients With Moderate Ischemic Mitral Regurgitation

TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades

Case Presentation: Cardiogenic Shock in a Patient With Non-ischemic Cardiomyopathy

TCT 792: Prognosis in Patients With Cardiogenic Shock According to Sex, With or Without Ischemic Cardiomyopathy

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

TCT 1351: Cangrelor in a Challenging Scenario of Concomitant Ischemic Stroke, Pulmonary Embolism and STEMI

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

TCT 104: Prognostic Impact of Ischemic Territory and Revascularization Strategy in Acute Myocardial Infarction Complicating Cardiogenic Shock Patients with Multi-vessel Disease

TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content